Choice - Morning Tea

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Maruti Suzuki India, country's largest car maker, has registered a rise of 29.10% in its total car sales (Domestic + Export) for the month of
October 2015 at 134,209 units, as against 103,973 units in 2014. The company's domestic sales rose by 24.7% in October 2015 at 121,063 units,
as against 97,069 units in corresponding month last year. Of the total, the company has sold 97951 units of its passenger cars during last month,
up by 21.5% as against 80589 units in 2014. The company's sales of vans have increased by 30.8% to 13677 units as against 10453 units in 2014.
Moreover, the company's sales of its utility vehicles rose by 56.5% to 9435 units from 6027 units in 2014. Moreover, the company's exports
have increased by 90.4% to 13,146 units as against 6,904 units in 2014.
Technical Outlook : On daily chart, stock has been trading in rising wedge formation and recently it has taken support of its lower band of wedge
pattern which is placed at 4370 levels. Moreover, stock has been trading above 21 DEMA on daily chart, which indicates that short term trend is
up. A momentum indictor RSI has remained above 40 levels on daily chart, which point out for positive breath in the stock. So for trading
perspective, one could Buy in the range of 4480-4500 for the Target of 4590 with the SL of 4435.
MARUTI
DRREDDY
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
03rd Nov 2015
Buy in the range of 4280-4300 for the Target of 4385 with the SL of 4237
Buy in the range of 4480-4500 for the Target of 4590 with the SL of 4435
Dr. Reddy's Laboratories has launched Nise D spray, emphasizing its strategic intent of being a player of substance in the Indian OTC (Over The
Counter) space. Nise D spray, offers quick and targeted pain killing. Through this product the company has further expanded its offerings in the
therapeutic area of pain relief to consumers. In India, the market for pain relief products is approximately Rs 1,700 crore. Pain relief sprays are
growing 20 times faster than creams and gels, indicating a trend of changing consumer preferences. The formulation for Nise D Spray comprises
3 key ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation. Dr. Reddy's is an integrated
global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses -
Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and
services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.
TechnicalOutlook:Thestockhasbeentradingwiththesupportofitsupwardrisingtrendlinewhichisplacedat4080levelsondailychart.Moreover,stockhasbeen
tradingabove60DEMAondailychartwhichindicatesthatmediumtolongtermtrendisup.AmomentumindictorRSIhasremainedabove40levelswhichpointout
forpositivebreathinthestock.Sofortradingperspective,onecouldBuyintherangeof4280-4300fortheTargetof4385withtheSLof4237.
US stocks added to their recent run with gains across all sectors on Monday, led by increases in the beaten-down energy group
and the acquisition-driven healthcare industry. The gains on the first trading day of the month followed the best monthly
performance of the major indexes in four years in October. The Nasdaq 100 on Monday closed at its highest level in more than 15
years. Data on Monday showed US manufacturing activity in October sank to a 2-1/2-year low, but a rise in new orders offered
encouragement. Elsewhere, factory activity in Germany beat economists' estimates, and manufacturing in Central and Eastern
Europe kept up a robust pace in October. The Dow Jones industrial average rose 165.22 points, or 0.94 percent, to 17,828.76, the
S&P 500 gained 24.69 points, or 1.19 percent, to 2,104.05 and the Nasdaq Composite added 73.40 points, or 1.45 percent, to
5,127.15.
Asian equity markets staged a comeback on Tuesday, with investors encouraged by the upbeat handover from Wall Street.
China's key Shanghai Composite index nudged up 0.1 percent amid jitters surrounding a crackdown on illegal futures trading and
ongoing anticorruption investigations into companies such as Dongfeng Motor Group. Shanghai Composite index traded at -
0.40% to 3311.81, Hang Seng index traded at 1.24 % to 22651.18, Japan's benchmark Nikkei 225 index traded at -2.14% to
18683.24, South Korea's Kospi index traded marginally up by 0.44 % to 2044.28 levels. The SGX Nifty suggests a flat to positive
opening for our markets as it is trading at 8105.50, up by 36.50 points

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Thirumalai Chemicals Limited; Interim Dividend - Rs 4/- Per Share (Purpose Revised)
Indo Count Industries Limited; Interim Dividend - Re 1/- Per Share
Result Calendar:
ABB, ADANIPOWER, AEGISLOG, ASAHIINDIA, BALRAMCHIN, BERGEPAINT, BOMDYEING,
CHAMBLFERT, DEN, DLF, FINANTECH, FINCABLES, GABRIEL, GAIL, GNFC, HEXAWARE, INDIAGLYCO,
IOC, KRBL, MCLEODRUSS, PFC, POWERGRID, PRISMCEM, PTC, PVR, RPOWER, SCHNEIDER, SFCL,
SHEMAROO, SICAGEN, SKIPPER, TBZ, TCIFINANCE, TECHM, TUBEINVEST.
03rd Nov 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr.No Deal Date Security Code Security Name Client Name Deal Type Quantity Price
1 2/11/2015 532614 IMPEXFERRO INDIAN INFOTECH AND SOFTWARE LIMITED S 425000 2.03
2 2/11/2015 522209 YOGISUNG BHARATKUMAR VELAJI MARWADI S 290709 9.46
3 2/11/2015 522209 YOGISUNG BHARATKUMAR VELAJI MARWADI B 290709 9.45
4 2/11/2015 522209 YOGISUNG UMESH BHIKHABHAI MAKWANA S 168541 9.45
5 2/11/2015 522209 YOGISUNG UMESH BHIKHABHAI MAKWANA B 168541 9.46
6 2/11/2015 522209 YOGISUNG MAHESHBHAI ARJUNBHAI BORISA S 115956 9.45
7 2/11/2015 522209 YOGISUNG MAHESHBHAI ARJUNBHAI BORISA B 115956 9.46
8 2/11/2015 539032 FRASER JIGNESH NARENDRABHAI PATEL B 101000 26.18
9 2/11/2015 522209 YOGISUNG NIRAJ RAJNIKANT SHAH B 100340 9.07
10 2/11/2015 522209 YOGISUNG KAMLESHBHAI RAMESHBHAI LUNAGARIYA S 99372 9.21

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
03rd Nov 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking Pvt
Ltd., ou=Research Dept.,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.11.03 08:24:16 +05'30'